0 items USD 0.00Search
- Did you mean
- rejuvenation idiopathic arthritis
Your search for "Juvenile idiopathic arthritis" gave back 1679 results.
The global Humira market size was valued at US$ 15980 million in 2024 and is forecast to a readjusted size of USD 8906 million by 2031 with a CAGR of...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
February 2025
Price: USD 3,480.00
Adalimumab, sold under the trade name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
April 2023
Price: USD 2,900.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
February 2024
Price: USD 2,900.00
The global Humira market size was valued at US$ 16700 million in 2023. With growing demand in downstream market, the Humira is forecast to a...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
January 2024
Price: USD 3,660.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
September 2024
Price: USD 3,480.00
The global Adalimumab market size was valued at US$ 142.8 million in 2023. With growing demand in downstream market, the Adalimumab is forecast to a...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
December 2024
Price: USD 3,660.00
The biologics used in Anti-inflammatory treatment – abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
February 2024
Price: USD 2,900.00
The biologics used in Anti-inflammatory treatment – abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
April 2023
Price: USD 2,900.00
Adalimumab, sold under the brand name Humira, among others, is a monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis,...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
April 2024
Price: USD 2,900.00
Etanercept is a medication used to manage and treat autoimmune conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis,...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
November 2024
Price: USD 3,950.00
The global Adalimumab Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Adalimumab Drug is forecast...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
October 2024
Price: USD 3,660.00
Adalimumab, sold under the trade name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
December 2024
Price: USD 4,900.00
The global Adalimumab market size was valued at USD 150.2 million in 2023 and is forecast to a readjusted size of USD 201.8 million by 2030 with a...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
December 2024
Price: USD 3,480.00
The global Adalimumab Drug market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
April 2025
Price: USD 3,480.00
Etanercept is a medication used to manage and treat autoimmune conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis,...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
November 2024
Price: USD 3,950.00
Ìý
